Company Profile

Abivax SA (NASDAQ: ABVX)
5:00 PM UTC, 07/03/24
Last: $13.07 Change: -0.43 %Change: -3.19% Volume: 8,262
Detailed Quote
Open: $ 13.54   Volume: 8,262
High: $ 13.54   Yield(%) 0.00
Low: $ 13.03   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 849.39M
EPS ($) n/a   Shares Out: 62.92M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 1.28
% Price Change (last 13 weeks): -3.85
% Price Change (last 26 weeks): 25.00
% Price Change (last 52 weeks): n/a
% Price Change (year to date): 26.17
Management Effectiveness
Return on Equity (%): -146.18
Return on Assets (%): -72.67
Return on Invested Capital (%): -101.92
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $14.10
200-day Moving Average: $n/a
Avg. Daily Vol. (last 50 days): 46,307
Avg. Daily Vol. (last 200 days): n/a
52-wk high: $n/a
52-wk low: $n/a
Bid: $13.01
Ask: $21.28
Company Information
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.
Abivax SA
7-11 Boulevard Haussmann
Paris IF 75009

Phone: 33.1.53.83.09.63
Fax: n/a
http://www.abivax.com
Per Share Data
Earnings (1year) ($): -3.71
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 3.44
Cash Flow ($): -2.53
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): 3.11
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 4.08
Current Ratio (x): 4.08
LT Debt/Equity (x): 22.89
Total Debt/Equity (x): 28.30



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.